Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess.
作者信息
de Zegher Francis, Ibáñez Lourdes
机构信息
Leuven Research & Development, University of Leuven, Leuven, Belgium.
Endocrinology Department, Institut de Recerca Sant Joan de Déu, University of Barcelona, Esplugues, Barcelona, Spain.
出版信息
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1680-1681. doi: 10.1111/aogs.14802. Epub 2024 Feb 10.
Abstract
摘要
相似文献
1
Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess.多囊卵巢综合征中的主导因素与次要因素：胰岛素抵抗与雄激素过多。
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1680-1681. doi: 10.1111/aogs.14802. Epub 2024 Feb 10.
2
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health.多囊卵巢综合征：起源与影响：多囊卵巢综合征：雄激素过多对代谢健康的影响。
Reproduction. 2025 Jul 4;170(2). doi: 10.1530/REP-25-0102. Print 2025 Aug 1.
3
The Role of Androgen Excess on Insulin Sensitivity in Women.雄激素过多与女性胰岛素敏感性的关系。
Front Horm Res. 2019;53:50-64. doi: 10.1159/000494902. Epub 2019 Sep 9.
4
Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome.多囊卵巢综合征中生殖功能障碍与代谢功能障碍之间的关联
Curr Opin Obstet Gynecol. 2025 Apr 29. doi: 10.1097/GCO.0000000000001037.
5
The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.游离雄激素指数的价值取决于多囊卵巢综合征的表型-单中心经验。
Endokrynol Pol. 2019;70(4):330-335. doi: 10.5603/EP.a2019.0017. Epub 2019 Apr 2.
6
Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.高雄激素血症在多囊卵巢综合征中对胰岛素抵抗及其他代谢特征的影响及作用
Acta Obstet Gynecol Scand. 2015 May;94(5):494-500. doi: 10.1111/aogs.12612. Epub 2015 Mar 19.
7
Free androgen index and Irisin in polycystic ovary syndrome.多囊卵巢综合征中的游离雄激素指数与鸢尾素
J Endocrinol Invest. 2016 May;39(5):549-56. doi: 10.1007/s40618-015-0403-7. Epub 2015 Nov 19.
8
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.饮食中碳水化合物的来源和含量与多囊卵巢综合征妇女的炎症反应。
Nutr Res Rev. 2018 Dec;31(2):291-301. doi: 10.1017/S0954422418000136. Epub 2018 Jul 23.
9
The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome.雄激素水平对多囊卵巢综合征患者血清代谢谱的影响。
Gynecol Endocrinol. 2024 Dec;40(1):2352136. doi: 10.1080/09513590.2024.2352136. Epub 2024 May 11.
10
Insulin resistance in polycystic ovary syndrome.多囊卵巢综合征中的胰岛素抵抗
Curr Opin Obstet Gynecol. 1997 Jun;9(3):193-201.
引用本文的文献
1
Sustained Metabolic Improvements with Low-Dose Metformin Combined with Oral Contraceptives in Female Adolescents with PCOS: A Single-Center Retrospective Cohort Study.低剂量二甲双胍联合口服避孕药对患有多囊卵巢综合征的女性青少年代谢的持续改善作用：一项单中心回顾性队列研究
Adv Ther. 2025 Jun 6. doi: 10.1007/s12325-025-03251-2.
2
The Role of Aromatic Amino Acids in Polycystic Ovary Syndrome through Patients' Blood Metabolic Profiling: A Systematic Review of the Past Five Years.通过患者血液代谢谱分析芳香族氨基酸在多囊卵巢综合征中的作用：过去五年的系统评价
J Proteome Res. 2025 May 2;24(5):2208-2221. doi: 10.1021/acs.jproteome.4c00937. Epub 2025 Apr 17.
3
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS.妊娠期糖尿病与多囊卵巢综合征：来自欧洲多囊卵巢综合征学会（EGOI-PCOS）的立场声明
Front Endocrinol (Lausanne). 2025 Jan 31;16:1501110. doi: 10.3389/fendo.2025.1501110. eCollection 2025.
4
Delphi consensus on the diagnostic criteria of polycystic ovary syndrome.多囊卵巢综合征诊断标准的德尔菲共识
J Endocrinol Invest. 2025 Jan 20. doi: 10.1007/s40618-025-02533-4.
5
Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis.多囊卵巢综合征和肾上腺增生中的高雄激素血症：寻找差异以做出明确诊断。
Arch Gynecol Obstet. 2025 Jan;311(1):25-32. doi: 10.1007/s00404-024-07897-1. Epub 2025 Jan 7.
6
Hyperandrogenic eumenorrheic NON-PCOS women women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone.高雄激素性月经正常的非多囊卵巢综合征女性；在使用地塞米松抑制肾上腺类固醇生成后进行促性腺激素释放激素激动剂刺激试验的多囊卵巢综合征女性。
J Clin Transl Endocrinol. 2024 Sep 6;37:100368. doi: 10.1016/j.jcte.2024.100368. eCollection 2024 Sep.
7
Bisphenol A in Water Systems: Risks to Polycystic Ovary Syndrome and Biochar-Based Adsorption Remediation: A Review.水系统中的双酚A：对多囊卵巢综合征的风险及基于生物炭的吸附修复：综述
Chem Biodivers. 2024 Dec;21(12):e202401037. doi: 10.1002/cbdv.202401037. Epub 2024 Nov 18.
8
New update of the international PCOS guideline-Focus on evidence-based medicine in the treatment of PCOS.国际多囊卵巢综合征指南的新更新——聚焦多囊卵巢综合征治疗中的循证医学。
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1682. doi: 10.1111/aogs.14892. Epub 2024 Jun 25.
9
Has the name PCOS run its course?多囊卵巢综合征（PCOS）这个名称是否已完成其使命？
Arch Gynecol Obstet. 2024 Sep;310(3):1761-1762. doi: 10.1007/s00404-024-07571-6. Epub 2024 Jun 5.
本文引用的文献
1
International evidence-based guideline on assessment and management of PCOS-A Nordic perspective.多囊卵巢综合征评估与管理的国际循证指南-北欧视角。
Acta Obstet Gynecol Scand. 2024 Jan;103(1):7-12. doi: 10.1111/aogs.14725. Epub 2023 Nov 20.
2
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见†。
Hum Reprod. 2023 Sep 5;38(9):1655-1679. doi: 10.1093/humrep/dead156.
3
Adolescent PCOS: a postpubertal central obesity syndrome.青春期多囊卵巢综合征：一种青春期后中心性肥胖综合征。
Trends Mol Med. 2023 May;29(5):354-363. doi: 10.1016/j.molmed.2023.02.006. Epub 2023 Mar 22.
4
Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome.走向使多囊卵巢综合征青春期女孩排卵率正常化的治疗方法。
J Endocr Soc. 2020 Mar 14;4(5):bvaa032. doi: 10.1210/jendso/bvaa032. eCollection 2020 May 1.
5
Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides.非酒精性脂肪性肝病、胰岛素抵抗与神经酰胺
N Engl J Med. 2019 Nov 7;381(19):1866-1869. doi: 10.1056/NEJMcibr1910023.
6
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.通过优先减少青少年多囊卵巢综合征患者肝内脏脂肪来规范排卵率。
J Adolesc Health. 2017 Oct;61(4):446-453. doi: 10.1016/j.jadohealth.2017.04.010. Epub 2017 Jul 14.
7
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.治疗青春期少女雄激素过多症：乙炔雌二醇-环丙孕酮酯与低剂量吡格列酮-氟他胺-二甲双胍。
J Clin Endocrinol Metab. 2011 Nov;96(11):3361-6. doi: 10.1210/jc.2011-1671. Epub 2011 Aug 24.
Zotero 插件